FDA panel to discuss Qnexa

FDA's Endocrinologic and Metabolic Drugs Advisory Committee has tentatively scheduled to meet July 15 to discuss an NDA from Vivus Inc. (NASDAQ:VVUS) for Qnexa phentermine/topiramate to treat obesity....